Literature DB >> 10356026

Cancer patients should be offered semen cryopreservation.

A Lass, N Abusheikha, F Akagbosu, P Brinsden.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10356026      PMCID： PMC1115918          DOI： 10.1136/bmj.318.7197.1556

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Risk of testicular cancer in subfertile men: case-control study.

Authors:  H Møller; N E Skakkebaek
Journal:  BMJ       Date:  1999-02-27

2.  A programme of semen cryopreservation for patients with malignant disease in a tertiary infertility centre: lessons from 8 years' experience.

Authors:  A Lass; F Akagbosu; N Abusheikha; M Hassouneh; M Blayney; S Avery; P Brinsden
Journal:  Hum Reprod       Date:  1998-11       Impact factor: 6.918

Review 3.  Fertility after chemotherapy for testicular germ cell cancer.

Authors:  J Pont; W Albrecht
Journal:  Fertil Steril       Date:  1997-07       Impact factor: 7.329

4.  Is routine pre-treatment cryopreservation of semen worthwhile in the management of patients with testicular cancer?

Authors:  S D Fosså; N Aass; K Molne
Journal:  Br J Urol       Date:  1989-11

Review 5.  Cancer and male infertility.

Authors:  D Meirow; J G Schenker
Journal:  Hum Reprod       Date:  1995-08       Impact factor: 6.918
  5 in total
  3 in total

1.  Semen Analysis in Cancer Patients Referred for Sperm Cryopreservation before Chemotherapy over a 15-Year Period in Korea.

Authors:  Ja Yoon Ku; Nam Cheol Park; Tae Gyeong Jeon; Hyun Jun Park
Journal:  World J Mens Health       Date:  2015-04-23       Impact factor: 5.400

Review 2.  Progress and future prospect of in vitro spermatogenesis.

Authors:  Fahar Ibtisham; Jiang Wu; Mei Xiao; Lilong An; Zachary Banker; Aamir Nawab; Yi Zhao; Guanghui Li
Journal:  Oncotarget       Date:  2017-07-27

3.  Semen cryopreservation, utilisation and reproductive outcome in men treated for Hodgkin's disease.

Authors:  F H Blackhall; A D Atkinson; M B Maaya; W D J Ryder; G Horne; D R Brison; B A Lieberman; J A Radford
Journal:  Br J Cancer       Date:  2002-08-12       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.